Pediatric Blood and Cancer

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Intermittent oral trimethoprim/sulfamethoxazole on two non‐consecutive days per week is effective as Pneumocystis jiroveci pneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation
Pediatric Blood and Cancer - Tập 52 Số 1 - Trang 142-144 - 2009
Yasuhisa Ohata, Hideaki Ohta, Yoshiko Hashii, Sadao Tokimasa, Keiichi Ozono, Junichi Hara
AbstractPneumocystis jiroveci pneumonia (PCP) is a serious complication in patients receiving chemotherapy or hematopoietic stem cell transplantation. Current recommendations for trimethoprim‐sulfamethoxazole (TMP‐SMZ) dosing as PCP prophylaxis in immunocompromised patients are based on either daily dosing or dosing three consecutive days...... hiện toàn bộ
Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells
Pediatric Blood and Cancer - Tập 55 Số 6 - Trang 1089-1095 - 2010
Justus Lieber, Bettina Kirchner, Carmen Eicher, Steven W. Warmann, Guido Seitz, Jörg Fuchs, Sorin Armeanu–Ebinger
Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison
Pediatric Blood and Cancer - Tập 63 Số 6 - Trang 1006-1011 - 2016
Tracy A. Marko, Brandon J. Diessner, Logan G. Spector
BackgroundOsteosarcoma (OS) is the most common primary malignant bone tumor in many countries, with metastatic disease responsible for most patient deaths. This study compares the prevalence of metastatic OS at diagnosis across countries to inform the critical question of whether diagnostic delay or tumor biology drives metastases development prior to dia...... hiện toàn bộ
Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR
Pediatric Blood and Cancer - Tập 65 Số 11 - 2018
А. Е. Druy, Egor Shorikov, Grigory Tsaur, А. М. Попов, A. N. Zaychikov, С. Н. Тупоногов, Leonid Saveliev, Godelieve A.M. Tytgat, Л. Г. Фечина
AbstractBackgroundDetection of bone marrow (BM) involvement in patients with neuroblastoma is crucial for staging and defining prognosis. Furthermore, the persistence of residual tumor cells in the BM is associated with an unfavorable outcome.MethodsExpression of ... hiện toàn bộ
Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow
Pediatric Blood and Cancer - Tập 45 Số 6 - Trang 787-795 - 2005
M. Fatih Okcu, Ruiyu Wang, Carlos E. Bueso‐Ramos, Wendy Schober, Douglas A. Weidner, Richard J. Andrassy, Martin L. Blakely, Heidi V. Russell, Alp Özkan, John F. Kuttesch, Michael Andreeff, Ka Wah Chan, Joann L. Ater
Development of anti‐asparaginase antibodies in childhood acute lymphoblastic leukemia
Pediatric Blood and Cancer - Tập 43 Số 5 - Trang 600-602 - 2004
Beata Zalewska‐Szewczyk, Witalij Andrzejewski, Jerzy Bodalski
AbstractL‐asparaginase is a basic agent of antileukemic therapy, but allergic reactions against the drug and the development of anti‐asparaginase antibodies are significant side‐effects. The aim of our study was to estimate the presence of anti‐asparaginase antibodies and to correlate the results with clinically apparent allergic reactions and wi...... hiện toàn bộ
Tandem high‐dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high‐risk medulloblastoma or supratentorial primitive neuro‐ectodermic tumors
Pediatric Blood and Cancer - Tập 61 Số 8 - Trang 1398-1402 - 2014
Christelle Dufour, Virginie Kieffer, Pascale Varlet, Marie Anne Raquin, F. Dhermain, Stéphanie Puget, Dominique Valteau‐Couanet, Jacques Grill
BackgroundTo assess the feasibility and effectiveness of high‐dose chemotherapy (HDC) with stem cell support followed by conventional craniospinal radiotherapy (RT) as treatment for children older than 5 years of age with newly diagnosed high‐risk medulloblastoma (MB) or supratentorial PNET (sPNET).Procedure... hiện toàn bộ
Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia
Pediatric Blood and Cancer - Tập 62 Số 7 - Trang 1277-1284 - 2015
Emily Riehm Meier, Jacqueline Dioguardi, Naynesh Kamani
BackgroundAllogeneic hematopoietic stem cell transplantation (HSCT) is the only available cure for sickle cell anemia (SCA). HSCT‐associated risks are one of many barriers to its widespread use for SCA. The study objective was to assess parent and patient perceptions of HSCT in the era of more widespread knowledge about HSCT for SCA.... hiện toàn bộ
The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations
Pediatric Blood and Cancer - Tập 56 Số 5 - Trang 789-793 - 2011
Amanda M. Brandow, Steven J. Weisman, Julie A. Panepinto
AbstractBackgroundSickle cell disease (SCD) pain is acute or chronic, leads to school absenteeism, impaired health‐related quality of life and early mortality. Given that little is known about children with SCD and chronic pain, we (1) described characteristics of these children and (2) evaluated the impact of a multidisciplinary ...... hiện toàn bộ
A pediatric translational perspective on the entity “progressive transformation of germinal centers (PTGC)”
Pediatric Blood and Cancer - Tập 60 Số 1 - Trang 3-4 - 2013
Rodney R. Miles, Mitchell S. Cairo
Tổng số: 53   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6